Abstract
A Randomized Phase Ii Trial of Standard Versus Low-Dose Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Cancer: JMTO LC14-01
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have